Artemis Medicare Services Limited — PPTs, 12-05-2025: Investor Presentation
1. Financial Highlights:
Artemis Hospitals’ gross revenue rose to ₹9,819 Mn (+6.5%), while EBITDA surged 31.9% to ₹1,848 Mn, with margins expanding to 19.7% from 15.9%. PAT more than doubled to ₹822 Mn, lifting PAT margin to 8.8%. Standalone EBITDA and PAT similarly posted strong gains of 34.7% and 69.8%, respectively. The balance sheet remains solid with shareholder funds at ₹8,418 Mn and cash reserves of ₹3,932 Mn, supporting growth investments.
2. Strategic Initiatives & Growth Drivers:
Capacity expanded through a new tower in Gurgaon, increasing beds beyond 700. Plans include a 300+ bed super-speciality hospital in Raipur, targeting Tier 2 city penetration. Artemis is emphasizing asset-light centers for network expansion, operational efficiency programs, and overseas growth with an 80-bed hospital in Mauritius. Fresh capital infusion of ₹330 Cr from IFC will fuel these initiatives and technology upgrades.
3. Business Developments:
Ongoing partnership with Philips continues to drive cardiac care services nationwide. The Raipur greenfield hospital marks a key geographic expansion. The recent tower launch and Mauritius operations diversify Artemis’ service footprint across 40+ specialties and 12 Centres of Excellence, reinforcing its multispeciality platform.
4. Market Position & Competitive Advantage:
As one of Delhi NCR’s largest premium hospital chains, Artemis boasts strong brand equity, clinical excellence, and technology leadership (including being the first JCI-accredited hospital in Gurgaon). A diverse patient base—including international and corporate clients—and scale in high-end quaternary care provide a competitive moat.
5. Investor Implications:
Robust margin and revenue growth paired with a strong balance sheet indicate positive growth potential. Expansion into Tier 2 cities and international markets diversifies risk and enhances scale. Successful execution of greenfield and asset-light projects will be critical value drivers. Monitoring operational efficiencies and ramp-up pace is key for investors.
